Author

J. I. Kim

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

C. Ju· 1 shared G. E. Lee· 1 shared H. Park· 1 shared H. Todo· 1 shared J. Cho· 1 shared J.-Y. Bae· 1 shared J.-Y. Lee· 1 shared M.-S. Park· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

C. Ju

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintDec 16, 2020

Disruption of Z-RNA-binding of ADAR1 induces Aicardi-Goutieres syndrome-like encephalopathy in mice

T. Nakahama, Y. Kato, T. Shibuya…·Y. Kawahara

This study shows that disrupting ADAR1 p150's Z-RNA-binding domain in mice causes AGS-like encephalopathy with type I IFN signature, which is alleviated by MDA5 deletion.

DOI 10.1101/2020.12.16.422984

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintJul 28, 2020

Pyronaridine and artesunate are potential antiviral drugs against COVID-19 and influenza

J.-Y. Bae, G. E. Lee, H. Park…·M.-S. Park

This study identifies pyronaridine and artesunate as potential antiviral drugs effective against SARS-CoV-2 and influenza viruses in human lung cells.

DOI 10.1101/2020.07.28.225102

humanexperimental assay

𝕏 PostBluesky